Table 4.

Distribution of patients by injection device and brand of filler type received

Variable	Men	%	Women	%	Combined	%
Total no. of treatment sessions during the study period, with any filler produce	1442	16.0	7556	84.0	8998a	100.0
No. injected by needle	205	14.2	1128	14.9	1333	14.8
No. delivered by cannula	1180	81.8	6099	80.7	7279	80.9
Volbella™, no. of treatments	79	5.5	398	5.3	477	5.3
Total volume, mL	74.4		320.4		394.8
Mean volume per treatment, mL	0.9		0.8		0.8
Voluma™, no. of treatments	1167	80.9	5846	77.4	7013	77.9
Total volume, mL	1631.7		6749.4		8381.1
Mean volume per treatment, mL	1.4		1.2		1.2
Volift™, no. of treatments	141	9.8	1157	15.3	1298	14.4
Total volume, mL	112.1		815.1		927.2
Mean volume per treatment, mL	0.8		0.7		0.7
Volux™, no. of treatments	29	2.0	97	1.3	126	1.4
Total volume, mL	34.0		88.7		122.7
Mean volume per treatment, mL	1.2		0.9		1.0
Other product, no. of treatments	26	1.8	58	0.8	84	0.9
Total volume, mL	24.6		50.5		75.1
Mean volume per treatment, mL	0.9		0.9		0.9

Voluma™, Volbella™, Volift™, and Volux™ are manufactured by Juvéderm.

^aThe 106-session discrepancy (8998 vs. 8892) in Tables 2 and 3 versus Table 4 is owing to data missing from the sample. These missing data were omitted from the complete-case statistical analysis.